Legis Daily

Finn Sawyer Access to Cancer Testing Act

USA118th CongressHR-1780| House 
| Updated: 12/17/2024
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (18)
Chris Pappas (Democratic)Raúl M. Grijalva (Democratic)Christopher R. Deluzio (Democratic)Jefferson Van Drew (Republican)Claudia Tenney (Republican)Terri A. Sewell (Democratic)Dina Titus (Democratic)Pete Sessions (Republican)Don Bacon (Republican)Andy Barr (Republican)Glenn Ivey (Democratic)Doris O. Matsui (Democratic)James A. Himes (Democratic)Joe Neguse (Democratic)Josh Gottheimer (Democratic)Jason Crow (Democratic)Debbie Wasserman Schultz (Democratic)Chellie Pingree (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Finn Sawyer Access to Cancer Testing Act This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 2, 2023

Latest Companion Bill Action

S 118-642
Introduced in Senate
Mar 24, 2023
Introduced in House
Mar 24, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 31, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • March 2, 2023

    Latest Companion Bill Action

    S 118-642
    Introduced in Senate


  • March 24, 2023
    Introduced in House


  • March 24, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 31, 2023
    Referred to the Subcommittee on Health.


  • December 17, 2024
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 118-642: Finn Sawyer Access to Cancer Testing Act
CancerHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careMedicaidMedical tests and diagnostic methodsMedicarePoverty and welfare assistanceState and local government operations

Finn Sawyer Access to Cancer Testing Act

USA118th CongressHR-1780| House 
| Updated: 12/17/2024
Finn Sawyer Access to Cancer Testing Act This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 2, 2023

Latest Companion Bill Action

S 118-642
Introduced in Senate
Mar 24, 2023
Introduced in House
Mar 24, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 31, 2023
Referred to the Subcommittee on Health.
Dec 17, 2024
Referred to the Subcommittee on Health.
  • March 2, 2023

    Latest Companion Bill Action

    S 118-642
    Introduced in Senate


  • March 24, 2023
    Introduced in House


  • March 24, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • March 31, 2023
    Referred to the Subcommittee on Health.


  • December 17, 2024
    Referred to the Subcommittee on Health.
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (18)
Chris Pappas (Democratic)Raúl M. Grijalva (Democratic)Christopher R. Deluzio (Democratic)Jefferson Van Drew (Republican)Claudia Tenney (Republican)Terri A. Sewell (Democratic)Dina Titus (Democratic)Pete Sessions (Republican)Don Bacon (Republican)Andy Barr (Republican)Glenn Ivey (Democratic)Doris O. Matsui (Democratic)James A. Himes (Democratic)Joe Neguse (Democratic)Josh Gottheimer (Democratic)Jason Crow (Democratic)Debbie Wasserman Schultz (Democratic)Chellie Pingree (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 118-642: Finn Sawyer Access to Cancer Testing Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
CancerHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careMedicaidMedical tests and diagnostic methodsMedicarePoverty and welfare assistanceState and local government operations